These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 28442121)
1. Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group. Kanwal F; Bacon BR; Beste LA; Brill JV; Gifford AL; Gordon SC; Horberg MA; Manthey JG; Reau N; Rustgi VK; Younossi ZM Gastroenterology; 2017 May; 152(6):1588-1598. PubMed ID: 28442121 [No Abstract] [Full Text] [Related]
2. American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection. Jacobson IM; Lim JK; Fried MW Gastroenterology; 2017 May; 152(6):1578-1587. PubMed ID: 28344022 [TBL] [Abstract][Full Text] [Related]
3. American Gastroenterological Association medical position statement on the management of hepatitis C. Dienstag JL; McHutchison JG Gastroenterology; 2006 Jan; 130(1):225-30. PubMed ID: 16401485 [No Abstract] [Full Text] [Related]
4. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists. Deming P; Martin MT; Chan J; Dilworth TJ; El-Lababidi R; Love BL; Mohammad RA; Nguyen A; Spooner LM; Wortman SB Pharmacotherapy; 2016 Feb; 36(2):203-17. PubMed ID: 26846728 [TBL] [Abstract][Full Text] [Related]
5. Geographically Focused Collocated Hepatitis C Screening and Treatment in Los Angeles's Skid Row. Benitez TM; Fernando SM; Amini C; Saab S Dig Dis Sci; 2020 Oct; 65(10):3023-3031. PubMed ID: 31974916 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus Infection in Patients With Cancer: Impact on Clinical Trial Enrollment, Selection of Therapy, and Prognosis. Torres HA; Pundhir P; Mallet V Gastroenterology; 2019 Oct; 157(4):909-916. PubMed ID: 30797794 [No Abstract] [Full Text] [Related]
7. Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment. Mühlbacher AC; Bridges JF; Bethge S; Dintsios CM; Schwalm A; Gerber-Grote A; Nübling M Eur J Health Econ; 2017 Mar; 18(2):155-165. PubMed ID: 26846922 [TBL] [Abstract][Full Text] [Related]
9. American Gastroenterological Association technical review on the management of hepatitis C. Dienstag JL; McHutchison JG Gastroenterology; 2006 Jan; 130(1):231-64; quiz 214-7. PubMed ID: 16401486 [No Abstract] [Full Text] [Related]
10. Hepatitis C therapy: Looking toward interferon-sparing regimens. Au TH; Destache CJ; Vivekanandan R J Am Pharm Assoc (2003); 2015; 55(2):e72-84; quiz e85-6. PubMed ID: 25658389 [TBL] [Abstract][Full Text] [Related]
11. Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosis. van der Meer AJ; Maan R; Veldt BJ; Feld JJ; Wedemeyer H; Dufour JF; Lammert F; Duarte-Rojo A; Manns MP; Zeuzem S; Hofmann WP; de Knegt RJ; Hansen BE; Janssen HL J Gastroenterol Hepatol; 2016 Jun; 31(6):1168-76. PubMed ID: 26647353 [TBL] [Abstract][Full Text] [Related]
12. Increasing antiviral treatment through integrated hepatitis C care: a randomized multicenter trial. Groessl EJ; Sklar M; Cheung RC; Bräu N; Ho SB Contemp Clin Trials; 2013 Jul; 35(2):97-107. PubMed ID: 23669414 [TBL] [Abstract][Full Text] [Related]
13. The Veterans Affairs Hepatitis C Treatment Considerations. Yee HS; Burton MJ; Belperio PS; Morgan TR Am J Gastroenterol; 2019 Feb; 114(2):185-188. PubMed ID: 30315291 [No Abstract] [Full Text] [Related]
15. Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration. Tabernilla A; Grandal M; Pernas B; Castro-Iglesias A; Rodríguez-Osorio I; Mena A; Delgado M; Cid P; Pedreira JD; Poveda E Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):781-785. PubMed ID: 28410351 [TBL] [Abstract][Full Text] [Related]
16. Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series. Childs-Kean LM; Hong J Gastroenterology; 2017 Oct; 153(4):1165-1166. PubMed ID: 28881195 [No Abstract] [Full Text] [Related]
17. Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam. Grady BP; Vanhommerig JW; Schinkel J; Weegink CJ; Bruisten SM; Lindenburg CE; Prins M Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1302-7. PubMed ID: 22825643 [TBL] [Abstract][Full Text] [Related]
18. Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents. Suraweera D; Saab EG; Tong MJ; Saab S Exp Clin Transplant; 2016 Jun; 14(3):243-51. PubMed ID: 27221717 [TBL] [Abstract][Full Text] [Related]
19. α-fetoprotein levels after interferon therapy predict regression of liver fibrosis in patients with sustained virological response. Tachi Y; Hirai T; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H J Gastroenterol Hepatol; 2016 May; 31(5):1001-8. PubMed ID: 27123974 [TBL] [Abstract][Full Text] [Related]
20. Diagnosing and treating hepatitis C virus infection. Schiff ER Am J Manag Care; 2011 Mar; 17 Suppl 4():S108-15. PubMed ID: 21767067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]